Benjamin J. Deadman
The synthesis of Bcr-Abl inhibiting anticancer pharmaceutical agents imatinib, nilotinib and dasatinib
Deadman, Benjamin J.; Hopkin, Mark D.; Baxendale, Ian R.; Ley, Steven V.
Citation
Deadman, B. J., Hopkin, M. D., Baxendale, I. R., & Ley, S. V. (2013). The synthesis of Bcr-Abl inhibiting anticancer pharmaceutical agents imatinib, nilotinib and dasatinib. Organic and Biomolecular Chemistry, 11(11), 1766-1800. https://doi.org/10.1039/c2ob27003j
| Journal Article Type | Article |
|---|---|
| Publication Date | 2013 |
| Deposit Date | Jul 14, 2014 |
| Journal | ORGANIC \& BIOMOLECULAR CHEMISTRY |
| Print ISSN | 1477-0520 |
| Electronic ISSN | 1477-0539 |
| Publisher | Royal Society of Chemistry |
| Volume | 11 |
| Issue | 11 |
| Pages | 1766-1800 |
| DOI | https://doi.org/10.1039/c2ob27003j |
You might also like
Spectroscopic dataset of Hedione's derivatives gathered during process development
(2022)
Journal Article
A simple one-pot oxidation protocol for the synthesis of dehydrohedione from Hedione
(2022)
Journal Article
Further investigations into imine-mediated formation of allylic nitro compounds
(2022)
Journal Article
Downloadable Citations
About Durham Research Online (DRO)
Administrator e-mail: dro.admin@durham.ac.uk
This application uses the following open-source libraries:
SheetJS Community Edition
Apache License Version 2.0 (http://www.apache.org/licenses/)
PDF.js
Apache License Version 2.0 (http://www.apache.org/licenses/)
Font Awesome
SIL OFL 1.1 (http://scripts.sil.org/OFL)
MIT License (http://opensource.org/licenses/mit-license.html)
CC BY 3.0 ( http://creativecommons.org/licenses/by/3.0/)
Powered by Worktribe © 2024
Advanced Search